ORGENTEC DIAGNOSTIKA GMBH Patent applications |
Patent application number | Title | Published |
20160047825 | METHOD AND REAGENT FOR DETERMINING VITAMIN D METABOLITES - The present invention relates to a method for releasing bound vitamin D by bringing a sample containing vitamin D into contact with a release reagent which contains at least one hydrotropic substance and at least one transition metal salt. The released vitamin D can subsequently be determined quantitatively. The present invention relates further to a reagent for releasing and optionally determining vitamin D, containing at least one hydrotropic substance and at least one transition metal salt, as well as to the use of such a release reagent for releasing and optionally determining vitamin D. | 02-18-2016 |
20160046703 | MONOSPECIFIC POLYPEPTIDE REAGENTS - The present invention relates to a novel antigen-binding protein construct or “modubody”, which contains at least three functional single domain modules of an antibody. The modubodies contain a domain from the heavy chain variable region of an antibody (VH), a domain from the light chain variable region of an antibody (VL) and bind monospecifically to an antigen. The modubodies further contain a domain from the constant region of antibodies. The modubodies can be used for diagnostic or therapeutic purposes. | 02-18-2016 |
20150241422 | Detecting an Analyte and Determining the Concentration of an Analyte Using Magnetizable Beads - The invention relates to methods, reagents and devices for detecting an analyte in a sample. | 08-27-2015 |
20120276099 | MONOSPECIFIC POLYPEPTIDE REAGENTS - The present invention relates to a novel antigen-binding protein construct or “modubody”, which contains at least three functional single domain modules of an antibody. The modubodies contain a domain from the heavy chain variable region of an antibody (VH), a domain from the light chain variable region of an antibody (VL) and bind monospecifically to an antigen. The modubodies further contain a domain from the constant region of antibodies. The modubodies can be used for diagnostic or therapeutic purposes. | 11-01-2012 |